Jasper Therapeutics, Inc.
JSPR · JSPRW · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Wiggans Thomas G: Form 4
Insider disclosure · Filed · Report period 31 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001788028 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- JSPR, JSPRW on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 2200 Bridge Pkwy Suite #102, Redwood City, CA, 94065
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Amplitude Healthcare Acquisition Corp (to 29 Sep 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields